Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

13 May 2021 07:00

RNS Number : 4583Y
Checkit PLC
13 May 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF UK MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

13 May 2021

Checkit plc

("Checkit" or the "Group")

 

Trading update

 

Checkit plc (AIM: CKT) announces an unaudited trading update for the three months to 30 April 2021:

 

Revenue for three months to

 

 

30 Apr

2021

30 Apr

2020 *

% Change

 

Checkit Connect:

Recurring

1.4

1.1

+30%

Non-recurring

0.3

0.6

(47) %

Total Checkit Connect

1.7

1.7

+1%

Checkit Connect US (Tutela LLC)**:

Recurring

0.1

0.1

+18%

Non-recurring

0.3

0.2

+32%

Total US

0.4

0.3

+29%

Total Checkit BEMS (Non-recurring)

2.2

1.7

+27%

Checkit Group:

Recurring

1.5

1.2

+29%

Non-recurring

2.8

2.5

+9%

Total Group

4.3

3.7

+15%

* Prior year revenue has been normalised to illustrate sales that would have been included in the Group's financial results had Tutela LLC, which was acquired on 4 February 2021, been fully owned by the Group throughout both periods. Excluding the acquisition of Tutela LLC, prior year Group revenue was £3.5m

** Checkit Connect US is introduced as a new reporting unit and is shown in GBP on a constant currency basis at a rate of 1.38 USD/GBP

 

Overall Group revenue grew by 15% and recurring revenue by 29% compared to the prior year on a normalised* basis.

 

Annual recurring revenue (ARR) saw an increase of £0.4m (+7%) in the quarter to close at a run rate of £6.1m, predominantly driven by new subscription contracts going live with customers.

 

Checkit Connect

 

Reported recurring revenue growth continues to reflect the benefits of year-on-year ARR growth realised in the quarter.

 

Some of the Group's larger hospitality customers impacted by lockdown measures were given the opportunity to take payment and service deferrals. This negatively affected Q1 reported numbers and is expected to unwind in Q2 as lockdown measures continue to ease.

 

The decline in non-recurring revenue compared to Q1 FY21 is primarily driven by timing and the on-going repositioning towards a subscription-based pricing model adopted across the Group during FY21.

 

Checkit US (Tutela LLC)

 

Checkit US is introduced for FY22 reporting and reflects the performance of the newly created US based business unit incorporating the Q1 acquisition of Tutela LLC.

 

US revenue grew by 29% in Q1 (on a constant currency basis**) and includes 18% growth in recurring revenue, which was driven by new subscriptions.

 

An initiative to convert customers to recurring subscription contracts is already underway.

 

Checkit BEMS

 

Checkit BEMS sales grew by 27% compared to the prior year due to a significant project delivered in the quarter and the impact of COVID-19 on prior year results in Q1 FY21.

 

Cash

 

Cash as at 30 April 2021 was £10.9m (31 January 2021: £11.5m).

 

During the period, the Group acquired Tutela LLC for £0.6m. Against this, the closing cash position benefitted from the disproportionate weighting of customer annual payments received in Q1 compared to other periods in the year. An unwinding of this cash benefit is expected during FY22.

 

Outlook

The Board remains confident in the outlook for the business.

 

As previously announced, during the current financial year, investment in sales, marketing and product will be increased to take advantage of the significant opportunities available for Checkit.

 

Forward looking statements

This document contains forward looking statements with respect to the business, strategy and plans of Checkit plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Checkit or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Checkit's actual future results may differ materially from the results expressed or implied in these forward-looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. The forward-looking statements contained in this document are made as of the date hereof, and Checkit undertakes no obligation to update any of its forward-looking statements.

 

 Checkit plc +44 (0) 1223 643313

 www.checkit.net

 Keith Daley (Executive Chair)

 Aylsa Muir (Chief Financial Officer)

 

 N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000

 Shaun Dobson / George Tzimas (Corporate Finance)

 Rachel Hayes (Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLLLFFELLBBE
Date   Source Headline
29th Mar 20187:00 amRNSBulgin announces agreement with Arrow Electronics
6th Mar 20187:00 amRNSFSA successfully completes trials with Checkit
27th Feb 20187:00 amRNSHolding(s) in Company
16th Feb 20187:00 amRNSDisposal of Queensgate Nano
8th Feb 20187:00 amRNSTrading Statement
26th Jan 20183:37 pmRNSHolding(s) in Company
25th Jan 20185:58 pmRNSHolding(s) in Company
25th Jan 20187:00 amRNSAcquisition of IP in EET business
19th Jan 20183:45 pmRNSHolding(s) in Company
2nd Jan 20187:00 amRNSChange of Nominated Adviser and Broker
12th Dec 20177:00 amRNSGrant of Options
6th Dec 20174:02 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSTrading Statement
23rd Oct 20174:16 pmRNSDirector/PDMR Shareholding
20th Oct 20177:00 amRNSDisposal of Sheen Instruments
16th Oct 201712:25 pmRNSHolding(s) in Company
27th Sep 20174:20 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
19th Sep 20177:00 amRNSContract Win
10th Aug 20177:00 amRNSTrading Update and Notification of Interim Results
31st Jul 20177:00 amRNSDisposal
13th Jul 201710:01 amRNSHolding(s) in Company
6th Jul 20173:00 pmRNSResult of AGM
6th Jul 20177:00 amRNSAGM Statement
16th Jun 201710:40 amRNSHolding(s) in Company
13th Jun 20177:57 amRNSHolding(s) in Company
6th Jun 201711:26 amRNSAnnual Report and Notice of AGM
18th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSNotice of Results & AGM
27th Mar 20177:00 amRNSDisposal
8th Feb 20177:00 amRNSTrading Update
19th Jan 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20164:54 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20169:00 amRNSReview of Operations
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company
20th Apr 20162:54 pmRNSDerivative Claim - Update
22nd Feb 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.